MassDevice Q&A

June 30, 2009 by MassDevice staff

Q&A Features

04/22/2013 by Brian Johnson

MassDevice talks disruptive business models in the medical device and hospital world with Novation executive and aptitude vice president Troy Kirchenbauer

Two years ago, Troy Kirchenbauer got an opportunity most employees would shy away from – the chance to put his company out of business.

The former Novation executive and current general manager of Aptitude LLC, a new web portal spunout of the Irving, TX.-based group purchasing organization, was tasked with leading a team with the mission of tearing apart not only Novation's business model, but the method by which hospitals buy billions of dollars of medical equipment...

04/10/2013 by Brian Johnson

Biomet CEO Jeff Binder tells MassDevice.com why gain sharing is bad for the medical device business and how the best is yet to come for the orthopedics sector.

Biomet CEO Jeff Binder

Two decades after he jumped ship from the Boston Consulting Group into the orthopedic world, the business of bones and joints still fascinates Jeff Binder, despite some of the headwinds the industry has faced over the past 5 years.

Maybe that's because the CEO of Warsaw, Ind.-based Biomet, a privately held orthopedic medical device company, is experienced enough to know the industry has been counted out before.

"...

04/03/2013 by Brian Johnson

Medical device company Entellus Medical is looking to change the standard of care in treating chronic sinusistis.

Entellus Medical

Brian Farley knows a little something about building a successful medical device company from the ground up.

Back in 1995 Farley was the 1st employee of VNUS Medical Technologies, which developed a catheter-based treatment for venous insufficiency. During his tenure as VNUS CEO, the company went public in 2004 before being acquired by Covidien (NYSE:...

03/27/2013 by Brian Johnson

Third Rock Ventures partner Neil Exter tells MassDevice.com about the firm's latest $516 million fund, how it plans to launch 15-16 new companies in the life sciences space and how its unique investment and development strategy paves the way for success.

Third Rock Ventures partner Neil Exter

Third Rock Ventures, one of the premiere healthcare venture capital firms, is loaded for bear again.

The Boston-based VC group recently closed its 3rd fund, a $516 million tranche that will go towards launching some 15 to16 new life science companies in the coming months. In the past 6...

03/21/2013 by Brian Johnson

Bill Walton tells to MassDevice.com about his work with medical device company NuVasive and its "Better Way Back" program.

Bill Walton

Even before the spine surgery he claims saved his life, Bill Walton's body was a marvel of medicine.

The Hall of Fame basketball player, who counts 2 NCAA national titles and 2 NBA championship rings to his name, has undergone 36 surgeries by his count, including 2 ankle fusions and a plethora of knee and foot procedures.

Despite that dubious pedigree, Walton told MassDevice.com that he was unprepared for the overwhelming nerve pain from a degenerative...

03/11/2013 by Arezu Sarvestani

Veteran cardiologist and patient safety advocate Dr. Robert Hauser tells MassDevice.com about his new vision for healthcare surveillance, his long struggle to spur change at the FDA and what FDA regulators can learn from aviation regulation.

Dr. Robert Hauser

Veteran cardiologist Dr. Robert Hauser is eager for change, even if he has to go straight to Capitol Hill himself to make it happen.

The patient safety advocate and vocal critic of the FDA announced at this year's American College of Cardiology conference that he's working on a proposal to...

Syndicate content
Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp